Johnson & Johnson Extends Dividend Streak Amid Talc Litigation Settlement Proposal
Johnson & Johnson (NYSE:JNJ) has extended its decades-long run of consecutive annual dividend increases, keeping it in an elite group known as Dividend Kings. This milestone places the company among a select few that have managed to grow their payouts without interruption over multiple decades.
The latest increase is attributed to the company's strong cash generation across its pharmaceutical and medical device segments. Despite facing patent cliffs, product recalls, and shifting industry dynamics, Johnson & Johnson has maintained its focus on durable growth drivers.
In a separate development, the company has proposed a settlement offer for its talc litigation, contingent on broad participation from claimant law firms. The move aims to resolve tens of thousands of claims tied to its legacy baby powder business.